What are the side effects of lenvatinib? How do patients use it?

At the forefront of anti-cancer treatment, lenvatinib has won widespread attention from the medical community due to its excellent efficacy and wide application. As a new generation of targeted therapy against tumor angiogenesis, lenvatinib is mainly used to treat unresectable hepatocellular carcinoma and other malignant tumors, lighting up new treatment hope for patients.

The therapeutic mechanism of lenvatinib is to inhibit the angiogenesis of tumor cells, thereby cutting off the nutrient supply to the tumor and effectively inhibiting tumor growth. Its significant efficacy is reflected in its ability to prolong the progression-free survival and overall survival of patients. Clinical research data show that compared with sorafenib, lenvatinib has a better effect in prolonging patient survival and has a higher objective response rate. This makes lenvatinib the preferred treatment option for many patients with liver cancer.

However, like other drugs, while lenvatinib is effective, it may also cause some side effects. When using it, patients should pay special attention to possible gastrointestinal reactions (such as diarrhea, nausea, vomiting, etc.), high blood pressure, fatigue, rash, and palmoplantar erythrodysesthesia syndrome. In addition, hematological toxicity (such as anemia, thrombocytopenia, etc.) and liver toxicity (such as elevated bilirubin, elevated transaminases, etc.) may occur. The severity of these side effects varies from individual to individual, and some patients may experience more severe reactions, in which case timely medical treatment is required.

In order to ensure the safe use of lenvatinib, patients should follow the following suggestions: First, be sure to use the drug rationally under the guidance of a doctor and strictly abide by the dosage and time; second, they should go to the hospital for regular review and closely monitor changes in liver function, kidney function, blood routine and other indicators; finally, if serious side effects or uncomfortable symptoms occur, the doctor should be informed immediately and corresponding treatment measures should be taken.

In summary, lenvatinib, as a highly effective anti-tumor drug, has demonstrated significant efficacy in prolonging patient survival. However, patients also need to pay close attention to possible side effects when using it, and use the medication rationally under the guidance of a doctor. Currently, lenvatinib is on the market in China, and patients can purchase and use it with medical advice. At the same time, affordable generic drugs are also available in overseas markets, providing patients with more treatment options.